SCHEMBL21185145

SCHEMBL21185145

O=C(NC1C2CC1C2)c1[nH]ccc(=O)c1OCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.50
EPHX2 P34913 5/20 0.42
ALDH1A1 P00352 3/20 0.41
USP2 O75604 1/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
NSD2 O96028 1/20 0.38
ABL1 P00519 1/20 0.38
PPARG P37231 1/20 0.38
RIN1 Q13671 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NCOR2 Q9Y618 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
HPGD P15428 2/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
SGMS2 Q8NHU3 1/20 0.37
LIPG Q9Y5X9 1/20 0.37
LMNA P02545 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22813445 0.88 POLB (0.47) POLBALDH1A1USP2TSHRHSD17B10
SCHEMBL10188498 0.86 POLB (0.52) POLBALDH1A1TSHRMEN1KMT2A
SCHEMBL21185213 0.85 POLB (0.49) POLBALDH1A1USP2TSHRHSD17B10
SCHEMBL10188493 0.81 POLB (0.60) POLBALDH1A1USP2TSHRHSD17B10
SCHEMBL10188488 0.79 POLB (0.64) POLBALDH1A1USP2TSHRHSD17B10
SCHEMBL19588885 0.79 POLB (0.58) POLBALDH1A1USP2TSHRHSD17B10
SCHEMBL21185208 0.79 FAAH (0.52) POLBEPHX2ALDH1A1USP2TSHR
SCHEMBL21259220 0.77 POLB (0.62) POLBALDH1A1USP2TSHRHSD17B10
SCHEMBL21274657 0.76 POLB (0.61) POLBALDH1A1USP2TSHRHSD17B10
SCHEMBL21185114 0.76 POLB (0.46) POLBALDH1A1USP2TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11247993-B2 Pyridone derivative, composition and use as antiviral drug thereof JIANGXI CAISHI PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2022-02-15 US disclosed
EP-3753936-A1 PYRIDONE DERIVATIVE, COMPOSITION THEREOF AND APPLICATION THEREOF AS ANTI-INFLUENZA DRUG Jiangxi Caishi Pharmaceutical Technology Co., Ltd. (CN) 2020-12-23 EP disclosed
WO-2019141179-A1 PYRIDONE DERIVATIVE, COMPOSITION THEREOF AND APPLICATION THEREOF AS ANTI-INFLUENZA DRUG 银杏树药业(苏州)有限公司 2019-07-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11247993-B2 Pyridone derivative, composition and use as antiviral drug thereof PNP, POLB, POLA1 POLB 2/4885EPHX2 1617/4885ALDH1A1 1847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.